Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer

The unexpected occurrence of thrombotic microangiopathy (TMA), characterised by microangiopathic haemolytic anaemia and thrombocytopenia, in a patient with cancer requires urgent diagnosis and appropriate management. TMA in patients with metastatic cancer can be a manifestation of the malignancy its...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Martin Hausberg, Helmut Felten, Stefan Pfeffer
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Karger Publishers 2019-01-01
Sarja:	Case Reports in Oncology
Aiheet:	aHUS Atypical Haemolytic Syndrome Bevacizumab Breast cancer Complement Eculizumab Metastases Mitomycin Thrombotic microangiopathy
Linkit:	https://www.karger.com/Article/FullText/495031
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!